Trial · NCT03038100
Adverse events764
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 764
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ANAEMIA | Blood and lymphatic system disorders | Atezolizumab With Paclitaxel, Carboplatin and Bevacizumab | 284 | 642 | 468 |
| other | ANAEMIA | Blood and lymphatic system disorders | Placebo With Paclitaxel, Carboplatin and Bevacizumab | 266 | 644 | 440 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | Atezolizumab With Paclitaxel, Carboplatin and Bevacizumab | 69 | 642 | 197 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | Placebo With Paclitaxel, Carboplatin and Bevacizumab | 76 | 644 | 243 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Atezolizumab With Paclitaxel, Carboplatin and Bevacizumab | 195 | 642 | 477 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Placebo With Paclitaxel, Carboplatin and Bevacizumab | 197 | 644 | 507 |
| other | THROMBOCYTOPENIA | Blood and lymphatic system disorders | Atezolizumab With Paclitaxel, Carboplatin and Bevacizumab | 137 | 642 | 278 |
| other | THROMBOCYTOPENIA | Blood and lymphatic system disorders | Placebo With Paclitaxel, Carboplatin and Bevacizumab | 134 | 644 | 275 |
| other | HYPERTHYROIDISM | Endocrine disorders | Atezolizumab With Paclitaxel, Carboplatin and Bevacizumab | 51 | 642 | 56 |
| other | HYPERTHYROIDISM | Endocrine disorders | Placebo With Paclitaxel, Carboplatin and Bevacizumab | 23 | 644 | 26 |
| other | HYPOTHYROIDISM | Endocrine disorders | Atezolizumab With Paclitaxel, Carboplatin and Bevacizumab | 118 | 642 | 131 |
| other | HYPOTHYROIDISM | Endocrine disorders | Placebo With Paclitaxel, Carboplatin and Bevacizumab | 54 | 644 | 57 |
| other | VISION BLURRED | Eye disorders | Atezolizumab With Paclitaxel, Carboplatin and Bevacizumab | 31 | 642 | 34 |
| other | VISION BLURRED | Eye disorders | Placebo With Paclitaxel, Carboplatin and Bevacizumab | 45 | 644 | 48 |
| other | ABDOMINAL DISTENSION | Gastrointestinal disorders | Atezolizumab With Paclitaxel, Carboplatin and Bevacizumab | 39 | 642 | 51 |
| other | ABDOMINAL DISTENSION | Gastrointestinal disorders | Placebo With Paclitaxel, Carboplatin and Bevacizumab | 49 | 644 | 60 |
| other | ABDOMINAL PAIN | Gastrointestinal disorders | Atezolizumab With Paclitaxel, Carboplatin and Bevacizumab | 182 | 642 | 253 |
| other | ABDOMINAL PAIN | Gastrointestinal disorders | Placebo With Paclitaxel, Carboplatin and Bevacizumab | 173 | 644 | 241 |
| other | ABDOMINAL PAIN UPPER | Gastrointestinal disorders | Atezolizumab With Paclitaxel, Carboplatin and Bevacizumab | 49 | 642 | 56 |
| other | ABDOMINAL PAIN UPPER | Gastrointestinal disorders | Placebo With Paclitaxel, Carboplatin and Bevacizumab | 66 | 644 | 98 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03038100/events